0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Letters to the Editor   |    
Antidepressant Use in Bipolar Disorder: Continuing an Age-Old Debate
Alan Eppel, M.B., F.R.C.P.C.
Am J Psychiatry 2010;167:1408-1408. doi:10.1176/appi.ajp.2010.10040496
View Author and Article Information
Hamilton, Ontario, Canada

The author reports no financial relationships with commercial interests.

accepted for publication in June 2010.

Accepted June , 2010.

Copyright © American Psychiatric Association

To the Editor: In their article published in the July 2010 issue of the Journal, Jay D. Amsterdam, M.D., and Justine Shults, Ph.D., (1) add more fuel to the three-decades old debate between those who advocate minimal use of antidepressants in the treatment of bipolar disorder and those who favor maximal usage (2). The authors are to be congratulated for addressing critical methodological parameters in their study: adequate duration (50 weeks) and inclusion of efforts to identify subsyndromal hypomania. Their results are nevertheless surprising. For clinicians and patients, the key question remains whether these results are clinically significant.

Eleven of 28 patients (39.2%) in the fluoxetine group had not relapsed at the end of the study. Even if we extrapolate this proportion to all 83 patients in the second phase of the study, the result is that only 21.6% of the original 148 patients would be deemed well at 50 weeks. This is a relapse rate of 78.4%. From the patient's point of view, these are very poor odds and do not represent a viable treatment option. The best evidence to date is that antidepressants have only a limited role in the treatment of bipolar disorder when long-term stability is seen as the goal of treatment (2).

Amsterdam  JD;  Shults  J:  Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo substitution study.  Am J Psychiatry 2010; 167:792—800
[CrossRef] | [PubMed]
 
Eppel  AB:  Antidepressants in the treatment of bipolar disorder: decoding contradictory evidence and opinion.  Harv Rev Psychiatry 2008: 16:205—209
[CrossRef] | [PubMed]
 
References Container
+

References

Amsterdam  JD;  Shults  J:  Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo substitution study.  Am J Psychiatry 2010; 167:792—800
[CrossRef] | [PubMed]
 
Eppel  AB:  Antidepressants in the treatment of bipolar disorder: decoding contradictory evidence and opinion.  Harv Rev Psychiatry 2008: 16:205—209
[CrossRef] | [PubMed]
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Web of Science® Times Cited: 1

Related Content
Books
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 1.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 2.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 23.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 16.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 38.  >
Topic Collections
Psychiatric News
APA Guidelines
PubMed Articles
[Childhood and adolescent depression]. Rev Prat 2014;64(4):487-90.